CVE-2024-45586

Account Take Over Vulnerability

Description

This vulnerability exists due to improper access controls on APIs in the Authentication module of Symphony XTS Web Trading and Mobile Trading platforms (version 2.0.0.1_P160). An authenticated remote attacker could exploit this vulnerability by manipulating parameters through HTTP request which could lead to unauthorized account take over belonging to other users.

Remediation

Solution:

  • Upgrade Symphony XTS Web Trader to version 2.0.0.1_P160_1 and Symphony XTS Mobile Trader to version 2.0.0.1_P160_1

Category

9.2
CVSS
Severity: Critical
CVSS 4.0 •
CVSS 3.1 •
EPSS 0.25%
Third-Party Advisory org.in
Affected: Symphony Fintech XTS Web Trader
Affected: Symphony Fintech XTS Mobile Trader
Published at:
Updated at:

References

Link Tags
https://www.cert-in.org.in/s2cMainServlet?pageid=PUBVLNOTES01&VLCODE=CIVN-2024-0281 third party advisory

Frequently Asked Questions

What is the severity of CVE-2024-45586?
CVE-2024-45586 has been scored as a critical severity vulnerability.
How to fix CVE-2024-45586?
To fix CVE-2024-45586: Upgrade Symphony XTS Web Trader to version 2.0.0.1_P160_1 and Symphony XTS Mobile Trader to version 2.0.0.1_P160_1
Is CVE-2024-45586 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-45586 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-45586?
CVE-2024-45586 affects Symphony Fintech XTS Web Trader, Symphony Fintech XTS Mobile Trader.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.